Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SGMS1 | Q86VZ5 | 9/20 | 0.56 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.53 |
| ▸ | F2 | P00734 | 2/20 | 0.53 |
| ▸ | PLG | P00747 | 1/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9850521 | 0.91 | SGMS1 (0.60) | SGMS1TBXA2RF2PLGTBXAS1 | |
| SCHEMBL9850445 | 0.91 | SGMS1 (0.54) | SGMS1TBXA2RF2PLGHSD17B10 | |
| SCHEMBL9850570 | 0.89 | SGMS1 (0.60) | SGMS1TBXA2RF2PLG | |
| SCHEMBL9850603 | 0.88 | SGMS1 (0.59) | SGMS1TBXA2RF2PLGHSD17B10 | |
| SCHEMBL9850329 | 0.88 | SGMS1 (0.59) | SGMS1TBXA2RF2PLGHSD17B10 | |
| SCHEMBL9850639 | 0.88 | F2 (0.57) | SGMS1TBXA2RF2PLGTBXAS1 | |
| SCHEMBL9130577 | 0.86 | SGMS1 (0.64) | SGMS1TBXA2RF2PLGHSD17B10 | |
| SCHEMBL9850395 | 0.85 | SGMS1 (0.55) | SGMS1TBXA2RF2PLGHSD17B10 | |
| SCHEMBL9127503 | 0.83 | TBXA2R (0.69) | SGMS1TBXA2RF2PLGAKR1C3 | |
| Hydrochloric Acid SCHEMBL9850342 | 0.82 | SGMS1 (0.50) | SGMS1TBXA2RF2PLGAKR1C3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0435085-A1 | Phenoxyalkylcarboxylic amides, process for their preparation and drug containing them | Roche Diagnostics GmbH (DE) | 1991-07-03 | — | — | EP | disclosed |